Syndax Pharmaceuticals
SNDX • NASDAQ • Stock Fundamentals
Syndax Pharmaceuticals is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Michael A. Metzger, with a market cap of $1.6B.
Market Cap$1.6B
Employees184.0
CEOMichael A. Metzger
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsApr 30, 2026 · 1 month 14 days agoQ1 2026
View reportNext EarningsAug 3, 2026 · in 2 monthsAfter Market Close · Q2 2026
Financials
Based on Q1 2026 filing
Syndax Pharmaceuticals FAQ
Common questions about Syndax Pharmaceuticals
Syndax Pharmaceuticals (SNDX) has a market capitalization of $1.6B and trades on NASDAQ.
Syndax Pharmaceuticals has approximately 184 employees.